Charalampos Antachopoulos

3.3k total citations · 1 hit paper
79 papers, 2.4k citations indexed

About

Charalampos Antachopoulos is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Charalampos Antachopoulos has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 38 papers in Infectious Diseases and 24 papers in Molecular Medicine. Recurrent topics in Charalampos Antachopoulos's work include Antifungal resistance and susceptibility (28 papers), Antibiotic Resistance in Bacteria (24 papers) and Fungal Infections and Studies (19 papers). Charalampos Antachopoulos is often cited by papers focused on Antifungal resistance and susceptibility (28 papers), Antibiotic Resistance in Bacteria (24 papers) and Fungal Infections and Studies (19 papers). Charalampos Antachopoulos collaborates with scholars based in Greece, United States and Australia. Charalampos Antachopoulos's co-authors include Emmanuel Roilides, Thomas J. Walsh, Joseph Meletiadis, Εlias Iosifidis, Athanasios Tsakris, Theodoros Karampatakis, Michael G. Rinaldi, Deanna A. Sutton, Yvonne R. Shea and Tin Sein and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Journal of Clinical Microbiology.

In The Last Decade

Charalampos Antachopoulos

73 papers receiving 2.3k citations

Hit Papers

Infections Caused byScedo... 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Infections Caused byScedosporiumspp
    2008 566 citations Emmanuel Roilides, Charalampos Antachopoulos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charalampos Antachopoulos Greece 28 1.3k 1.3k 547 414 260 79 2.4k
Chris Kosmidis United Kingdom 25 1.2k 1.0× 1.1k 0.9× 504 0.9× 257 0.6× 265 1.0× 77 2.3k
Hiroshi Kakeya Japan 31 1.9k 1.5× 1.9k 1.5× 327 0.6× 262 0.6× 669 2.6× 253 3.5k
F. Jacobs Belgium 26 1.1k 0.9× 1.2k 1.0× 510 0.9× 452 1.1× 426 1.6× 62 2.5k
Axel Hamprecht Germany 29 879 0.7× 912 0.7× 1.1k 1.9× 302 0.7× 318 1.2× 103 2.4k
F Sánchez Spain 27 1.3k 1.0× 1.5k 1.2× 179 0.3× 222 0.5× 245 0.9× 83 2.5k
Gary J. Moet United States 19 1.7k 1.3× 1.1k 0.9× 314 0.6× 232 0.6× 276 1.1× 24 2.3k
Diego R. Falci Brazil 18 619 0.5× 923 0.7× 784 1.4× 668 1.6× 144 0.6× 66 1.7k
Eiman Mokaddas Kuwait 34 1.8k 1.5× 1.8k 1.4× 334 0.6× 118 0.3× 411 1.6× 112 2.7k
C C Knapp United States 24 1.1k 0.9× 875 0.7× 335 0.6× 372 0.9× 192 0.7× 49 1.7k
Y. J. Debets-Ossenkopp Netherlands 23 1.4k 1.1× 1.1k 0.9× 267 0.5× 116 0.3× 205 0.8× 38 2.4k

Countries citing papers authored by Charalampos Antachopoulos

Since Specialization
Citations

This map shows the geographic impact of Charalampos Antachopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalampos Antachopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalampos Antachopoulos more than expected).

Fields of papers citing papers by Charalampos Antachopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charalampos Antachopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalampos Antachopoulos. The network helps show where Charalampos Antachopoulos may publish in the future.

Co-authorship network of co-authors of Charalampos Antachopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Charalampos Antachopoulos. A scholar is included among the top collaborators of Charalampos Antachopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charalampos Antachopoulos. Charalampos Antachopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romani, Lorenza, Matteo Di Nardo, Gabriella Bottari, et al.. (2023). The Use of Cefiderocol as Salvage Therapy in an Infant Receiving ECMO and Continuous Renal Replacement Therapy. Antibiotics. 13(1). 37–37. 5 indexed citations
2.
3.
Simitsopoulou, Maria, et al.. (2022). Daptomycin exerts differential immunomodulatory effects on host responses against methicillin-resistant Staphylococcus aureus biofilms. International Journal of Antimicrobial Agents. 60(4). 106666–106666. 1 indexed citations
4.
Papakonstantinou, Εvgenia, et al.. (2022). Paediatric cutaneous mucormycosis: A case report and review of the literature. Mycoses. 65(7). 674–682. 6 indexed citations
5.
Simitsopoulou, Maria, et al.. (2021). Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of Scedosporium and Fusarium spp.. Antimicrobial Agents and Chemotherapy. 65(11). e0063821–e0063821. 5 indexed citations
6.
Xinias, Ioannis, et al.. (2021). Covid-19: Face Mask Protection in the Pediatric Setting. MAEDICA – a Journal of Clinical Medicine. 16(1).
7.
Simitsopoulou, Maria, et al.. (2020). Immunomodulatory effects of colistin on host responses against carbapenem-resistant Klebsiella pneumoniae biofilms. International Journal of Antimicrobial Agents. 56(6). 106182–106182. 7 indexed citations
8.
Simitsopoulou, Maria, et al.. (2019). Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms. Antimicrobial Agents and Chemotherapy. 63(3). 19 indexed citations
9.
Karampatakis, Theodoros, Katerina Tsergouli, Εlias Iosifidis, et al.. (2019). Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care. Microbial Drug Resistance. 25(9). 1347–1356. 8 indexed citations
10.
Karampatakis, Theodoros, Katerina Tsergouli, Lida Politi, et al.. (2019). Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit. Molecular Biology Reports. 46(3). 3497–3500. 10 indexed citations
11.
Karampatakis, Theodoros, Katerina Tsergouli, Εlias Iosifidis, et al.. (2019). Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area. Journal of Global Antimicrobial Resistance. 20. 214–218. 2 indexed citations
12.
Xinias, Ioannis, et al.. (2019). Thiamine Deficiency in a Child with Short Bowel Syndrome and Review. Pediatric Gastroenterology Hepatology & Nutrition. 22(5). 493–493. 9 indexed citations
13.
Iosifidis, Εlias, Charalampos Antachopoulos, Eleni Volakli, et al.. (2019). Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit. Acta Paediatrica. 108(10). 1923–1924. 2 indexed citations
14.
Karampatakis, Theodoros, Katerina Tsergouli, Lida Politi, et al.. (2018). Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit. Microbial Drug Resistance. 25(5). 712–716. 18 indexed citations
15.
Antachopoulos, Charalampos, Stavroula Ilia, Eirini Baira, et al.. (2018). Pharmacokinetics of Daptomycin in Critically Ill Pediatric Patients. Antimicrobial Agents and Chemotherapy. 62(6). 7 indexed citations
16.
Karampatakis, Theodoros, Charalampos Antachopoulos, Athanasios Tsakris, & Emmanuel Roilides. (2018). Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data. European Journal of Clinical Microbiology & Infectious Diseases. 37(7). 1211–1220. 38 indexed citations
17.
Pyrpasopoulou, Athina, Κωνσταντίνα Κοντοπούλου, Konstantinos Kitsios, et al.. (2016). A Rare Case of Disseminated Pyogenic Gonococcal Infection in an Immunocompetent Woman. SHILAP Revista de lepidopterología. 2016. 1–4. 4 indexed citations
18.
Antachopoulos, Charalampos, et al.. (2016). A Rare Case of Clavicle Osteomyelitis in a Child and Literature Review. SHILAP Revista de lepidopterología. 2016. 1–5. 10 indexed citations
19.
Iosifidis, Εlias, Charalampos Antachopoulos, Maria Ioannidou, et al.. (2010). Colistin administration to pediatric and neonatal patients. European Journal of Pediatrics. 169(7). 867–874. 63 indexed citations
20.
Iosifidis, Εlias, Charalampos Antachopoulos, Maria Tsivitanidou, et al.. (2008). Differential Correlation Between Rates of Antimicrobial Drug Consumption and Prevalence of Antimicrobial Resistance in a Tertiary Care Hospital in Greece. Infection Control and Hospital Epidemiology. 29(7). 615–622. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Kosmidis Breakdown of academic impact, for papers by Hiroshi Kakeya Breakdown of academic impact, for papers by F. Jacobs Breakdown of academic impact, for papers by Axel Hamprecht Breakdown of academic impact, for papers by F Sánchez Breakdown of academic impact, for papers by Gary J. Moet Breakdown of academic impact, for papers by Diego R. Falci Breakdown of academic impact, for papers by Eiman Mokaddas Breakdown of academic impact, for papers by C C Knapp Breakdown of academic impact, for papers by Y. J. Debets-Ossenkopp
Rankless by CCL
2026